1-6 of 6
Lubomir Sokol
Close
Sort by
Journal Articles

Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma

Clinical Trials & Observations
Thomas E. Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz, Alejandro Martin Martin Garcia-Sancho, Ranjana H Advani, Josep Maria Roncero Vidal, Raquel De Oña, Ana Marin-Niebla, Antonia Rodriguez Izquierdo, Maria José Terol, MD, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine M Foss
Journal: Blood Advances
Blood Adv bloodadvances.2024012806.
https://doi.org/10.1182/bloodadvances.2024012806
Published: 2024
Includes: Supplemental data
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

Sézary syndrome originates from heavily mutated hematopoietic progenitors

Carly M. Harro, Kimberly B. Sprenger, Ricardo A. Chaurio, John J. Powers, Patrick Innamarato, Carmen M. Anadon, Yumeng Zhang, Subir Biswas, Gunjan Mandal, Jessica A. Mine, Carla Cortina, Mate Z. Nagy, Alexandra L. Martin, Katelyn F. Handley, Gustavo J. Borjas, Pei-Ling Chen, Javier Pinilla-Ibarz, Lubomir Sokol, Xiaoqing Yu, Jose R. Conejo-Garcia
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5586–5602.
https://doi.org/10.1182/bloodadvances.2022008562
Published: 2023
Includes: Supplemental data
Journal Articles

Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma

Clinical Trials & Observations
Jeremy S. Abramson, Elizabeth Bengston, Robert Redd, Jeffrey A. Barnes, Tak Takvorian, Lubomir Sokol, Frederick Lansigan, Philippe Armand, Bijal Shah, Eric Jacobsen, Rosalba Martignetti, Elyce Turba, Sara Metzler, Victoria Patterson, Ann S. LaCasce, Celeste M. Bello
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1130–1136.
https://doi.org/10.1182/bloodadvances.2022008420
Published: 2023
Journal Articles

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Clinical Trials & Observations
Seongseok Yun, Onyee Chan, Daniel Kerr, Nicole D. Vincelette, Afshan Idrees, Qianxing Mo, Kendra Sweet, Jeffrey E. Lancet, Mohamed A. Kharfan-Dabaja, Ling Zhang, Lubomir Sokol
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3435–3442.
https://doi.org/10.1182/bloodadvances.2020001875
Published: 2020
Includes: Supplemental data
Journal Articles

Non-del(5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis

Kathy L. McGraw, Chia-Ho Cheng, Y. Ann Chen, Hsin-An Hou, Björn Nilsson, Giulio Genovese, Thomas Cluzeau, Andrea Pellagatti, Bartlomiej P. Przychodzen, Mar Mallo, Leonor Arenillas, Azim Mohamedali, Lionel Adès, David A. Sallman, Eric Padron, Lubomir Sokol, Chimene Moreilhon, Sophie Raynaud, Hwei-Fang Tien, Jacqueline Boultwood, Benjamin L. Ebert, Francesc Sole, Pierre Fenaux, Ghulam J. Mufti, Jaroslaw P. Maciejewski, Peter A. Kanetsky, Alan F. List
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3579–3589.
https://doi.org/10.1182/bloodadvances.2019000922
Published: 2019
Includes: Supplemental data